{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:51Z","timestamp":1794898911277,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00384-020-03528-8","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T10:02:57Z","timestamp":1581328977000},"page":"695-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-315X","authenticated-orcid":false,"given":"Zenghong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-6911","authenticated-orcid":false,"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-5154","authenticated-orcid":false,"given":"Qi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-4213","authenticated-orcid":false,"given":"Zhuokai","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8716-2840","authenticated-orcid":false,"given":"Yumo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-7973","authenticated-orcid":false,"given":"Du","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-7931","authenticated-orcid":false,"given":"Liangliang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6063-189X","authenticated-orcid":false,"given":"Guannan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-4591","authenticated-orcid":false,"given":"Meijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5200-3997","authenticated-orcid":false,"given":"Yanxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-1615","authenticated-orcid":false,"given":"Huichuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"3528_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7\u201334","journal-title":"CA Cancer J Clin"},{"key":"3528_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683\u2013691","journal-title":"Gut"},{"key":"3528_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","volume":"12","author":"M Horowitz","year":"2015","unstructured":"Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S (2015) Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 12:213\u2013226","journal-title":"Nat Rev Clin Oncol"},{"key":"3528_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-019-1058-3","volume":"18","author":"Z Chen","year":"2019","unstructured":"Chen Z, Zhang P, Xu Y et al (2019) Surgical stress and cancer progression: the twisted tango. Mol Cancer 18:132","journal-title":"Mol Cancer"},{"key":"3528_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","volume":"15","author":"JG Hiller","year":"2018","unstructured":"Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK (2018) Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol 15:205\u2013218","journal-title":"Nat Rev Clin Oncol"},{"key":"3528_CR6","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","volume":"25","author":"AE Tuomisto","year":"2019","unstructured":"Tuomisto AE, Makinen MJ, Vayrynen JP (2019) Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol 25:4383\u20134404","journal-title":"World J Gastroenterol"},{"key":"3528_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51:27\u201341","journal-title":"Immunity"},{"key":"3528_CR8","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1172\/JCI127282","volume":"129","author":"D Panigrahy","year":"2019","unstructured":"Panigrahy D, Gartung A, Yang J, Yang H, Gilligan MM, Sulciner ML, Bhasin SS, Bielenberg DR, Chang J, Schmidt BA, Piwowarski J, Fishbein A, Soler-Ferran D, Sparks MA, Staffa SJ, Sukhatme V, Hammock BD, Kieran MW, Huang S, Bhasin M, Serhan CN, Sukhatme VP (2019) Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases. J Clin Invest 129:2964\u20132979","journal-title":"J Clin Invest"},{"key":"3528_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1213\/ANE.0000000000001652","volume":"124","author":"MW Sekandarzad","year":"2017","unstructured":"Sekandarzad MW, van Zundert AAJ, Lirk PB, Doornebal CW, Hollmann MW (2017) Perioperative anesthesia care and tumor progression. Anesth Analg 124:1697\u20131708","journal-title":"Anesth Analg"},{"key":"3528_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","volume":"9","author":"MJ Thun","year":"2012","unstructured":"Thun MJ, Jacobs EJ, Patrono C (2012) The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9:259\u2013267","journal-title":"Nat Rev Clin Oncol"},{"key":"3528_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.7326\/M15-0039","volume":"163","author":"S Friis","year":"2015","unstructured":"Friis S, Riis AH, Erichsen R, Baron JA, Sorensen HT (2015) Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case-control study. Ann Intern Med 163:347\u2013355","journal-title":"Ann Intern Med"},{"key":"3528_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/jnci\/djy042","volume":"110","author":"C Desmedt","year":"2018","unstructured":"Desmedt C, Demicheli R, Fornili M et al (2018) Potential benefit of intra-operative administration of ketorolac on breast cancer recurrence according to the patient\u2019s body mass index. J Natl Cancer Inst 110:1115\u20131122","journal-title":"J Natl Cancer Inst"},{"key":"3528_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/107327481602300312","volume":"23","author":"BM Lee","year":"2016","unstructured":"Lee BM, Rodriguez A, Mena G, Gottumukkala V, Mehran RJ, Rice DC, Feng L, Yu J, Cata JP (2016) Platelet-to-lymphocyte ratio and use of NSAIDs during the perioperative period as prognostic indicators in patients with NSCLC undergoing surgery. Cancer Control 23:284\u2013294","journal-title":"Cancer Control"},{"key":"3528_CR14","doi-asserted-by":"crossref","unstructured":"Schack A, Oho AUID, Fransgaard T, Klein MF, Gogenur I (2019) Perioperative use of nonsteroidal anti-inflammatory drugs decreases the risk of recurrence of cancer after colorectal resection: a cohort study based on prospective data. Ann Surg Oncol","DOI":"10.1245\/s10434-019-07600-8"},{"key":"3528_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/bja\/aex225","volume":"119","author":"JP Cata","year":"2017","unstructured":"Cata JP, Guerra CE, Chang GJ, Gottumukkala V, Joshi GP (2017) Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth 119:750\u2013764","journal-title":"Br J Anaesth"},{"key":"3528_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.clcc.2017.03.015","volume":"16","author":"S Rossi","year":"2017","unstructured":"Rossi S, Basso M, Strippoli A, Schinzari G, D\u2019Argento E, Larocca M, Cassano A, Barone C (2017) Are markers of systemic inflammation good prognostic indicators in colorectal cancer. Clin Colorectal Cancer 16:264\u2013274","journal-title":"Clin Colorectal Cancer"},{"key":"3528_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/bjc.2015.183","volume":"113","author":"CH Koh","year":"2015","unstructured":"Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, Jamaris S, Taib NA (2015) Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 113:150\u2013158","journal-title":"Br J Cancer"},{"key":"3528_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ijc.30060","volume":"139","author":"QT Zhao","year":"2016","unstructured":"Zhao QT, Yuan Z, Zhang H, Zhang XP, Wang HE, Wang ZK, Duan GC (2016) Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: a meta-analysis including 3,720 patients. Int J Cancer 139:164\u2013170","journal-title":"Int J Cancer"},{"key":"3528_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fonc.2019.00757","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang X, Ni X, Tang G (2019) Prognostic role of platelet-to-lymphocyte ratio in patients with bladder cancer: a meta-analysis. Front Oncol 9:757","journal-title":"Front Oncol"},{"key":"3528_CR20","first-page":"1053125","volume":"2017","author":"XZ Huang","year":"2017","unstructured":"Huang XZ, Chen WJ, Zhang X et al (2017) An elevated platelet-to-lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with colorectal cancer: a meta-analysis. Dis Markers 2017:1053125","journal-title":"Dis Markers"},{"key":"3528_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00292-010-1349-3","volume":"31","author":"C Wittekind","year":"2010","unstructured":"Wittekind C (2010) 2010 TNM system: on the 7th edition of TNM classification of malignant tumors. Pathologe 31:331\u2013332","journal-title":"Pathologe"},{"key":"3528_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12879-017-2280-5","volume":"17","author":"E Raffetti","year":"2017","unstructured":"Raffetti E, Donato F, Casari S et al (2017) Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study. BMC Infect Dis 17:193","journal-title":"BMC Infect Dis"},{"key":"3528_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3748\/wjg.v25.i1.118","volume":"25","author":"DL Ren","year":"2019","unstructured":"Ren DL, Li J, Yu HC, Peng SY, Lin WD, Wang XL, Ghoorun RA, Luo YX (2019) Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol 25:118\u2013137","journal-title":"World J Gastroenterol"},{"key":"3528_CR24","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/JCO.2016.66.6198","volume":"34","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L, Chen D, Cao J, Wei H, Peng X, Huang Z, Cai G, Zhao R, Huang Z, Xu L, Zhou H, Wei Y, Zhang H, Zheng J, Huang Y, Zhou Z, Cai Y, Kang L, Huang M, Peng J, Ren D, Wang J (2016) Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial. J Clin Oncol 34:3300\u20133307","journal-title":"J Clin Oncol"},{"key":"3528_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00464-018-6355-1","volume":"33","author":"A Modasi","year":"2019","unstructured":"Modasi A, Pace D, Godwin M, Smith C, Curtis B (2019) NSAID administration post colorectal surgery increases anastomotic leak rate: systematic review\/meta-analysis. Surg Endosc 33:879\u2013885","journal-title":"Surg Endosc"},{"key":"3528_CR26","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.ejso.2017.06.010","volume":"43","author":"HD Kverneng","year":"2017","unstructured":"Kverneng HD, Angenete E, Lydrup ML, Ruteg\u00e5rd J, Matthiessen P, Ruteg\u00e5rd M (2017) Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer. Eur J Surg Oncol 43:1908\u20131914","journal-title":"Eur J Surg Oncol"},{"key":"3528_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/1055-9965.EPI-17-0876","volume":"27","author":"CN Kuo","year":"2018","unstructured":"Kuo CN, Pan JJ, Huang YW, Tsai HJ, Chang WC (2018) Association between nonsteroidal anti-inflammatory drugs and colorectal cancer: a population-based case-control study. Cancer Epidemiol Biomark Prev 27:737\u2013745","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3528_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/gut.2010.221143","volume":"60","author":"AE Coghill","year":"2011","unstructured":"Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM (2011) Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut 60:491\u2013498","journal-title":"Gut"},{"key":"3528_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1053\/j.gastro.2016.07.030","volume":"151","author":"Y Cao","year":"2016","unstructured":"Cao Y, Nishihara R, Qian ZR et al (2016) Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology 151:879\u2013892.e4","journal-title":"Gastroenterology"},{"key":"3528_CR30","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1200\/JCO.2017.72.3569","volume":"35","author":"X Hua","year":"2017","unstructured":"Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA (2017) Timing of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survival. J Clin Oncol 35:2806\u20132813","journal-title":"J Clin Oncol"},{"key":"3528_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.2015.336","volume":"113","author":"A Restivo","year":"2015","unstructured":"Restivo A, Cocco IM, Casula G, Scintu F, Cabras F, Scartozzi M, Zorcolo L (2015) Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer 113:1133\u20131139","journal-title":"Br J Cancer"},{"key":"3528_CR32","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/bja\/aet068","volume":"110","author":"JP Cata","year":"2013","unstructured":"Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI (2013) Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 110:690\u2013701","journal-title":"Br J Anaesth"},{"key":"3528_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1186\/s12885-018-4641-x","volume":"18","author":"HP Redmond","year":"2018","unstructured":"Redmond HP, Neary PM, Jinih M et al (2018) RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial. BMC Cancer 18:794","journal-title":"BMC Cancer"},{"key":"3528_CR34","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","volume":"20","author":"E Gurpinar","year":"2014","unstructured":"Gurpinar E, Grizzle WE, Piazza GA (2014) NSAIDs inhibit tumorigenesis, but how. Clin Cancer Res 20:1104\u20131113","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-020-03528-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:59:19Z","timestamp":1612918759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-020-03528-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3528"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03528-8","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"5 February 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional Medicine Ethics Committee of The Sixth Affiliated Hospital, Sun Yat-sen University, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All data and materials as well as software application or custom code support published claims and comply with field standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data transparency"}}]}}